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A B S T R A C T
Background: Antibodies are one of the most important tools in biological research. High specificity and sensi-
tivity of antibodies are crucial to obtain reliable results. Tissue fixed with glutaraldehyde (GA) is commonly used
in electron microscopical investigations. The fixation and embedding routine in preparation of tissue for post-
embedding electron microscopy (EM) will mask and structurally alter epitopes, making antibody-antigen in-
teraction inefficient, with low labeling intensities. One of the main factors in this regard is the use of GA as
fixative.
New method: To alleviate these technical challenges, we immunized rabbits with antigen pre-fixed with GA. We
hypothesized that the resulting antibodies would have stronger affinity to antigens that have been con-
formationally changed and denatured by GA, the way they are in fixed tissue.
Comparison with existing method and results: An initial screening with western blotting (WB) showed results
consistent with our hypothesis. In-house antibodies raised against GA-fixed SNARE proteins SNAP-25 and
VAMP2, binds more strongly to fixed proteins compared to non-fixed proteins, while the pattern is opposite with
the commercially available antibodies raised against non-fixed antigens (standard antibodies). Quantitative post-
embedding EM of hippocampal synapses gave higher labeling intensities with anti-GA-SNAP-25 and anti-GA-
VAMP2 compared to standard antibodies. Importantly, light microscopy (LM) and EM with our antibodies re-
vealed stronger labeling of GA-fixed than formaldehyde (FH) treated brains.
Conclusion: Our results highlight the experimental potential of raising antibodies against GA-treated antigen to
improve sensitivity of the antibodies for postembedding immunogold EM.
1. Introduction
Fixation of tissue is required to prevent postmortem decay, such as
autolysis and putrefaction (Hladik, 2009). Fixation will also increase
mechanical strength of the tissue as well as prevent bacterial coloni-
zation. In addition, the structure of the biological material is preserved
so that they are very similar to that found in living organisms (Fox
et al., 1985). The two most commonly used fixatives are GA and FA
(Keiernan, 2000). Both are crosslinking fixatives and react with amino
groups of protein and thus cross-link polypeptide chains (Sewell et al.,
1984). GA is a larger molecule and diffusion through membranes is
lower compared to FA. The advantage of GA is quick fixation and two
aldehyde groups available that can act as a bridge between two proteins
that are located more distantly from each other (Monsan et al., 1975).
Weak fixatives with little or no GA provide optimum preservation of
antigenicity and hence the strongest signal for immunocytochemistry.
Strong fixatives, with a high concentration of GA, provide the best ul-
trastructure but may severely distort or mask target epitopes (Hayat,
2002).
The fixation and embedding routine in preparation of tissue for EM
influences antigenicity, resulting in a markedly reduced labeling in-
tensity and often increased background (Mathiisen et al., 2006). To
overcome these technical challenges, we immunized rabbits with an-
tigen pre-fixed with GA. We hypothesized that the resulting antibodies
would have stronger affinity to antigens that have been con-
formationally changed and denatured by GA, the way they are in fixed
tissue. SNARE proteins SNAP-25 and VAMP2 (also called synapto-
brevin-2) were selected for immunization of the rabbits. Both proteins
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are members of a highly conserved family termed SNAREs (Fasshauer
et al., 1998). These proteins together with syntaxin1 form a SNARE
complex crucial for membrane fusion (Hussain and Davanger, 2011,
2015; Hussain et al., 2016, 2018). VAMP2 is associated with vesicles
and termed a v-SNARE (vesicle-SNARE) while SNAP-25 is localized on
plasma membrane and termed a t-SNARE (target-SNARE). The pairing
of cognate v- and t-SNAREs between two opposing lipid bilayers drives
membrane fusion and confers specificity to intracellular membrane
trafficking (Hussain and Davanger, 2011; Hussain et al., 2017; Sollner
et al., 1993). Crude antiserum was affinity purified against recombinant
VAMP2 and SNAP-25 protein, both of them pre-fixed with GA. Anti-GA-
SNAP-25 and anti-GA-VAMP2 antibodies were compared to similar
commercially available polyclonal and monoclonal standard antibodies
to determine whether they in fact more readily bind to fixed, denatured,
protein than the standard antibodies. We further investigated sensi-
tivity of GA-protein antibodies for GA- compared to FA-fixed brains. WB
of synaptosomes, immunofluorescence (IF) labeling of neuronal cul-
tures, LM of immunocytochemically stained brain sections, and post-
embedding immunogold labeling of the hippocampus for EM were used
to evaluate the performance of the antibodies.
2. Material and methods
2.1. Antibodies
GA-protein-antibodies: Anti-GA-VAMP2 and anti-GA-SNAP-25 were
raised in rabbit. Recombinant VAMP2 and SNAP-25 proteins were fixed
in 1.25% GA before being mixed with Freunds adjuvant and used for
immunization. Crude antiserum was affinity purified against the same
recombinant VAMP2 and SNAP-25 protein fixed with 1.25% glutar-
aldehyde (see below). Anti-GA-VAMP2 was used at 1:200 000 for WB,
1:300 for IF, 1:50 for LM, and 1:10 for EM. Anti-GA-SNAP-25 was used
at 1:50 000 for WB, 1:100 for IF, 1:50 for LM, and 1:30 for EM.
Purchased polyclonal antibodies: Anti-VAMP2 (AbCam, Cambridge,
UK, Cat#Ab70222) was used at 1:1500 for WB, 1:300 for IF and 1:350
for EM. Anti-SNAP-25 (AbCam, Cambridge, UK, Cat#41455) was used
at 1:25 000 for WB, 1:300 for IF and 1:10 for EM. Anti-syntaxin1
(Alomone, Jerusalem, Israel, Cat#ANR-002) was used at 1:300 for LM.
Purchased monoclonal antibodies: Anti-VAMP2 (Covance, New
Jersey, USA, Cat#MMS-616R) was used at 1:2000 for WB, 1:50 for IF
and 1:10 for EM. Anti-SNAP-25 (Covance, New Jersey, USA, Cat#MMS-
614R) was used at 1:5000 for WB, 1:300 for IF and 1:10 for EM.
The absolute concentration (e.g., μg/μl) of primary antibodies used
in this study was unknown. Different antibodies, however, against the
same antigen used at the same absolute concentrations will still have
different affinities to the antigen. Thus, comparing different antibodies
used at the same absolute concentrations will be of little value. In the
current study, we have taken care to optimize the concentration for
each antibody individually before comparing immunogold labeling in-
tensities. We used series of dilutions in titration experiments. The op-
timal dilution was then selected based on specific labeling intensity of
synaptic membranes combined with low non-specific labeling of mi-
tochondria.
The following secondary antibodies were used: IgG coupled to
10 nm colloidal gold (British BioCell International, Cardiff, UK,
Cat#AR14007) was used at 1:40 for EM. Goat anti-rabbit alkaline
phosphatase (Sigma, MO, USA, Cat#A3687) and goat anti-mouse al-
kaline phosphatase (Sigma, MO, USA, Cat#A3562) were used at 1:10
000 for WB. Alexa fluor 488 (Thermo Fisher Scientific, Massachusetts,
USA) donkey anti-rabbit (Cat#A21206) and donkey anti-mouse
(Cat#A21202) were used at 1:1000 for IF. Biotynilated goat anti-rabbit
(Abcam, Cambridge, UK, Cat#Ab64256) ready to use for LM.
Streptavidin biotinylated horseradish peroxidase complex (GE health-
care, Buckinghamshire, United Kingdom, Cat#RPN1051 V) was used at
1:100 for LM.
2.2. Animals
Wistar male rats weighing 250–300 g were used for EM, 1–4 day old
Wistar rats for primary hippocampal cultures, PVG male rats weighing
200–250 g for WB and LM. SNAP-25 knock-out (KO) mice (Washbourne
et al., 2002) and VAMP2 KO mice (Schoch et al., 2001) were used to
evaluate antibody specificity. Experimental protocols were approved by
the Institutional Animal Care and Use Committee and conform to Na-
tional Institutes of Health guidelines for the care and use of animals, as
well as international laws on protection of laboratory animals, with the
approval of a local bioethical committee and under the supervision of a
veterinary commission for animal care and comfort of the University of
Oslo. The animals were treated in accordance with the guidelines of the
Norwegian Committees on Animal Experimentation (Norwegian An-
imal Welfare Act and European Communities Council, Directive of 24
November 1986-86/609/EEC). Every effort was made to minimize the
number of animals used and their sufferings.
2.3. Antibody production and purification
2.3.1. Bacteria clones
We obtained bacteria clones for SNAP-25 and VAMP2 as a gift from
Richard Scheller. A cDNA probe corresponding to nucleotides 21-302
from VAMP2 and 209-829 from SNAP-25 were cloned into pGEX-KG
vector and expressed as fusion protein in E. coli.
2.3.2. Sequence analysis of plasmid
The bacteria clones for SNAP-25 and VAMP2 were grown on Luria-
Broth agar plates containing ampicillin 50 μg/ml at 37 °C. Single colony
was transferred to 2xYT-medium (bacto-tryptone 16 g/l, bacto yeast
extract 10 g/l, NaCl 5 g/l) containing 20 μg/ml in the incubator at 37 °C
and 220–250 rpm. The bacteria were grown to reach an absorbance
A600 0.6–0.7. The standard protocol from Qiagen was used to isolate
DNA. Restriction enzyme analysis and sequencing of DNA were per-
formed to verify the inserted sequence.
2.3.3. Expression of GST-fusion protein
SNAP-25 and VAMP2 GST-fusion proteins were expressed and
purified (Guan and Dixon, 1991). Bacteria were first grown in 10ml
2xYT-medium with 50 μg/ml ampicillin in incubator at 37 °C and
220–250 rpm. Overnight (ON) culture was mixed with 1 L 2xYT media
containing 20 μg/ml ampicillin and grown further in the incubator for
3 h at 37 °C (absorbance 0.6–0.7). Isopropyl BD-thiogalactoside was
added to the culture to a final concentration of 0.4mM and incubated at
37 °C for 2 h. The culture was centrifuged at 5000 rpm for 5min at 4 °C
using Sorvall RC 5B Plus centrifuge (SLA 1500 rotor). All the further
steps were performed at 4 °C. The pellet was resuspended in 10ml (1/
100) of the following solution: 150mM NaCl, 16mM Na2HPO4 (pH
7,3), 4 mM NaH2PO4 (pH 7.3), 2 mM EDTA, 0.1% phenylmethylsulfonyl
fluoride (resolved PMSF in ethanol), 5mM Benzamidin and 1% Triton
X-100. Lysozyme 2mg/ml was added to the resuspension and incubated
on ice for 10min. Added 40mM MgCl2 and 10 μg/ml deoxyr-
ibonuclease and incubated on ice for 15min. Sonicated with a Vibracell
(Soniks and Materials Inc. Danbury, CT USA), 10×30 s, amplitude 70.
Each tube contained 5ml suspension. Centrifuged at 10 000 rpm for
10min in a Sorvall RC 5B plus centrifuge (SS-34 rotor). Supernatant
contained the expressed soluble protein.
2.3.4. Purification of GST fusion protein
A column with Glutathione Sepharose 4B (Amersham Biosciences)
was used for purification of the protein. The supernatant was applied to
the column. After flow through of the supernatant, the column was
washed first with 20ml sodium phosphate buffer (SPB) and then 10x
bed volume of thrombin cutting buffer (50mM Tris-HCl, pH 8.0,
150mM NaCl, 2.5mM CaCl2, 0.1% B-mercaptoetanol). To cut the GST
tag from the fusion protein, thrombin (5–10 μg/ml beads) was added to
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the column and incubated ON at 4 °C. The eluated protein was col-
lected. The column was then incubated with 1x bed volume thrombin
cutting buffer for 10min and the flow through was collected. This
process was repeated 5 times. Glycerol was added to the eluated protein
in a concentration of 20% on ice. The protein was stored at -80 °C.
2.3.5. Fixation of antigen with glutaraldehyde
Antigen was divided into 8 different tubes and GA added to a final
concentration of 1.25%. The samples were shaken a few times until
they got a yellow colour, and incubated at 4 °C for 2.5 h. Stock solution
of 1M glycine in phosphate buffer was added to the tubes to a final
concentration of 200mM and incubated for 1.5 h at 4 °C. Samples were
then transferred to dialysis tubes. The tubes were incubated in a large
beaker containing 0.2M phosphate buffer ON on a magnetic stirrer at
4 °C. The next day, the buffer was changed three times with 6 h interval.
The samples were stored at -80 °C.
2.3.6. Immunization of rabbit
Two rabbits were used for immunization of each antigen. 100 μg of
antigen was mixed with complete Freund adjuvant to a total volume of
1ml and injected intramuscularly. Two weeks later, the rabbits were
injected with 100 μg (1ml) of antigen mixed with incomplete Freund
adjuvant. After 10 days, the antibody reached peak levels. Blood sam-
ples were incubated 1 h at room temperature (RT) and centrifuged at
3500 rpm for 10min. The serum was stored at −80 °C.
2.3.7. Affinity purification of the antibodies
Affinity purification was based on affigel-15/affigel-10
(Amersham). The procedure was performed in a cold room with cold
solutions. The affigel was stored in propanol at −20 °C. 10ml affigel
was mixed with acidic water on a shaker to allow swelling. A tube with
3mg peptide and HEPES (50mM, pH 8.0) was prepared, added to the
affigel, mixed immediatelyand incubated ON. A column with the mix-
ture of peptide and affigel was prepared. We used 10 column volumes
of affigel to initialize the columns with starting buffer (50mM Tris
buffer, pH 7.4, 300mM NaCl, 0.1% NaN3 and 1mM EDTA). Anti-serum
was applied to the column. The flow rate was adjusted to 1 h. The
column was re-initialized with washing buffer. The antibodies were
eluted with two column volumes of elution buffer (100ml: 10ml 2M
Glycine-HCl pH 2.5, 5ml 3M NaCl, 1 ml 0.5M EDTA, 0.5 ml 20%
NaN3). The eluate was collected directly in to 2ml of 2M HEPES buffer
(pH 8). PMSF was added to the eluted IgG to a final concentration of
1mM. The antibodies were stored at -80 °C.
2.4. Subcellular fractionation
Preparation of synaptosome and vesicle membrane fractions: Ten
rats were decapitated, the brains were dissected out and submerged in
ice-cold HEPES-buffered sucrose (0.32M sucrose, 4.0mM HEPES, pH
7.4) containing a protease inhibitor cocktail (Promega, Winconsin,
USA). The tissue was homogenized in HEPES buffer with a glass-teflon
homogenizer (900 rpm, 10–15 strokes) and centrifuged (800–1000 g,
10min, 4 °C). The postnuclear supernatant, S1, was centrifuged (10
000 g, 15min). The pellet containing crude synaptosomes was re-
suspended in 10 volumes of HEPES-buffered sucrose and centrifuged
(10 000 g, 15min) to yield a washed crude synaptosomal fraction. The
synaptosomal fraction was resuspended in 10mM sucrose, layered onto
1.2M sucrose and centrifuged (161 000 g, 25min). The gradient in-
terphase was collected, diluted in HEPES-buffered sucrose and layered
on 0.8M sucrose and centrifuged again (161 000 g, 25min) to get a
pellet containing pure synaptosomes.
2.5. Immunoblotting
WB analysis was performed using Criterion Cell and Criterion
Blotter system (BioRad, CA, USA). Equal amounts of the protein were
loaded on Criterion 4–20 % pre-cast gel (BioRad), separated by elec-
trophoresis at 200 V for 50min and electroblotted onto PVDF mem-
brane (Hoefer Scientific Instruments, CA, USA) at 100 V for 60min. The
membranes were blocked with 5% non-fat dried milk powder in TBST
(0.05% Tween-20) for 60min and incubated with primary antibodies
and 2.5% non-fat dried milk powder in TBST at RT, ON. The mem-
branes were washed three times for 10min in TBST and then incubated
for 1 h with alkaline–phosphatase linked secondary antibodies and
1.25% non-fat dried milk powder in TBST. The membranes were wa-
shed three times for 10min in TBST. Signals were detected by using ECF
substrate (Amersham Biosciences, UK) according to the manufacturers
protocol. The membranes were scanned using a fluorescence digital
camera detection system (Typhoon scanner).
2.6. Bright field microscopic studies
Free floating vibratome sections (50 μm) from rat brain were treated
with 1.0M ethanolamine-HCL in 0.1M SPB, pH 7.4 for 30min. After
washing 3 times×1min, the sections were incubated in blocking
buffer solution (BB) (10% normal goat serum in SPB) for 1 h and then
incubated with primary antibody in BB ON/RT. The next day, the
sections were rinsed in SPB, 3 times× 5min and BB for 20min. The
sections were then incubated in biotinylated secondary antibody di-
luted in BB for 1 h at RT and washed 3 times×5min with SPB. The
sections were further incubated with streptavidin-biotinylated horse-
radish peroxidase diluted in BB for one hour and washed in SPB 5
times×10min. Finally, the sections were incubated in 0.05% diami-
nobenzidine (DAB) in SPB for 5min, before 0.01% H2O2 and 0.05%
DAB diluted in SPB for 6min, before final washing in SPB 3 times×
5min. The sections were mounted on microscope slides with heated
glycerol gelatin and cover slides. Images of histological sections were
acquired using an automated slide scanner system (Axio Scan Z1, Carl
Zeiss Microscopy, Munich, Germany) and Leica Microscope
(DM5500B).
2.7. Preparation of hippocampal neuronal cultures
Primary hippocampal cultures containing both neurons and glial
cells of 1–4 days old rats were prepared as previously described
(Hasegawa et al., 2004). The cultures were maintained in cell medium:
Gibcos MEM with the addition of 30mg/100ml glutamine, 2.5mg/
100ml insulin, 5–10 % fetal calf serum, 2ml/100ml B-27 and 2–10 μl/
100ml ARA-C in 5% CO2, in an incubator with 95% air and 5% CO2 at
37 °C. The cultures were used for experiments after 14–21 days. The
cells were fixed in 4.0% FA or 2.5% GA by the following procedure:
freshly prepared fixative in 0.1M SPB was heated to 37 °C before
adding it to the culture medium (equal volumes). After 30min, this
mixture was substituted with 0.4% FA or 0.25% GA in 0.1M SPB ON.
The cells were stored in 0.4 F A or 0.25% GA in 0.1M SPB. The sections
were labeled with primary antibody in 2% (v/v) normal calf serum
(NCS), 1% (w/v) bovine serum albumin and 0.4% saponin in SPB (ON/
RT). The sections were rinsed in SPB, incubated for 30min with sec-
ondary antibodies at RT and rinsed again in SPB. The tissue sections
were mounted with fluormont mounting medium (Southern Biotech,
Alabama, USA), and images were obtained with an Axioplan 2
equipped with a LSM 5 Pa scanner head (Carl Zeiss, Heidelberg, Ger-
many).
2.8. Perfusion fixation of the rats
For EM studies the rats were deeply anesthetized with Equithesin
(0.4ml/100 g body weight) followed by intracardiac perfusion with
10–15 s flush of 4% Dextran-T70 in SPB (pH 7.4) followed by 2.5% GA
(one rat), 4% FA (one rat) or a mixture of 4% FA and 0.1% GA (three
rats) in SPB. Each rat was perfused with 500ml fixative over
15–20min. The rats were then left ON in a cold room. The next day, the
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brains were carefully dissected out and stored in SPB with 0.25% GA,
0.4% FA or a mixture of 0.4% FA/0.01% GA.
2.9. Freeze substitution
Small blocks (0.5–1.0mm) from the CA1 region of the hippocampus
were freeze substituted as follows: The small tissue blocks were cryo-
protected in increasing concentrations of glycerol (30min in 10%,
30min in 20%, and overnight in 30% at 4 °C) in 0.1M phosphate buffer
and then frozen in a cryofixation unit (Reichert KF80, Vienna, Austria)
filled with propane which was cooled down by liquid nitrogen.
Afterwards, the tissue was transferred to 1.5% uranyl acetate diluted in
anhydrous methanol into the pre-cooled chamber (−90 °C, ON). The
tissue pieces were placed in Reichert capsules in a flow-through
chamber filled with 1.5% uranyl acetate diluted in anhydrous methanol
in a pre-cooled chamber (−90 °C) in a Reichert Automatic Freeze-
Substitution unit (AFS) (Leica, Germany). Following 30 h in −90 °C, the
temperature was raised with 4 °C increments per hour from −90 °C to
−45 °C. The tissue pieces were then rinsed with anhydrous methanol
and infiltrated with Lowicryl HM20 resin (Polysciences, Inc.,
Warrington, PA 18976, Cat#15924). Infiltration in 1:1 and 2:1 in me-
thanol to pure Lowicryl lasted for 2 h each, and 2 h in pure Lowicryl as
well as ON in pure Lowicryl. The Reichert capsules were moved to
Lowicryl-filled gelatin capsules and then transferred to another con-
tainer filled with ethanol. The resin/tissue was polymerized with UV-
light for 24 h, still at −45 °C. The temperature was increased by 5 °C
increments to a final 0 °C where it was polymerized for further 35 h.
Ultra-thin sections (90 nm) were cut with a diamond knife (Diatome
ultra 45°, Diatome, U.S.) on an ultramicrotome (Reichert Ultracut S-
2.GA-E-12/92, Leica Microsystems, Germany) and placed on coated
(Coat-Quick “G”) nickel grids (Electron Microscopy Sciences, G300-Ni).
2.10. Postembedding immunocytochemistery
Three rats were fixed with a mixture of 4.0% FA and 0.1% GA.
Ultrathin sections from the rats were labeled with GA-protein anti-
bodies and standard monoclonal antibodies in a screening experiment.
In all three rats, stronger labeling intensity was observed with GA-
protein antibodies. The rat with the best ultrastructure was then used
for the detailed quantitative analysis (see below). One rat fixed with
2.5% GA and one rat fixed with 4.0% FA were used for immunogold
labeling with GA-protein antibodies in order to determine sensitivity of
these antibodies for GA-fixed tissue. From each animal, six small
(0.5–1.0 mm) blocks from the CA1 region of the hippocampus were
freeze substituted. From each animal, one block with the best ultra-
structure was selected for quantification. Three ultrathin sections from
each block were immunolabeled essentially as described previously
(Mathiisen et al., 2006). The sections were incubated in TBST (Tris
buffered saline with Tween20) buffer containing 50mM glycine
(10min) and in TBST containing 2% human serum albumin (HSA)
(10min) to neutralize free aldehyde groups and blocking nonspecific
antibody binding sites respectively. The sections were incubated with
primary antibody diluted in 2% HSA in TBS with 0.01% Triton X-100)
ON at RT. The sections was rinsed and immersed in TBST (10min) and
then incubated in 10 nm goat anti-rabbit IgG colloidal gold-secondary
antibody 1:20, in 2% HSA and 1mg/ml PEG in TBST for 90min at RT.
The sections were then rinsed with distilled water and post-stained with
2% uranyl acetate (90 s) and 0.3% lead citrate (90 s). Uranyl acetate
and lead citrate were removed with distilled water, and sections were
left to dry completely before examination in the electron microscope. A
total of 60 synaptic profiles were used for each antibody for comparing
GA-protein antibodies to standard antibodies. A total of 50 synaptic
profiles were used for each antibody for comparing sensitivity of GA-
protein antibodies for GA and FA fixed tissue. Images with clearly
visible pre- and post-synaptic plasma membranes and vesicles mem-
branes were selected for quantitative analysis for each antibody. From
each image of a synapse, we examined one region of interest (ROI);
either the active zone for SNAP-25 quantification or the presynaptic
cytoplasm for VAMP2 quantification.
Pre-incubation experiments: One block with the best ultrastructure
from the animals fixed with a combination of 4% FA and 0.1% GA was
selected for immunolabeling with anti-GA-SNAP-25 and anti-GA-
VAMP2 antibodies after pre-incubation with the same antigen used for
immunization of the rabbits. Two sections from the pre-incubation
group and two sections from the control group were immunolabeled.
Ten synaptic profiles from each section were quantified. A total of 20
profiles were quantified in each group.
SNAP-25 and VAMP2 KO mice: Embryos were killed by decapita-
tion. Left and right hippocampi were dissected and immersed in fixative
solution (4.0% FA/0.1% GA SPB). We used immersion fixation of new-
born SNAP-25 and VAMP2 KO mice since these animals die im-
mediately after birth. Hippocampi from three KO and three wild-type
(WT) mice were embedded with freeze substitution. Two animals/
blocks with the best ultrastructure from each group were selected. Two
ultrathin sections from each animal/block were immunolabeled. Five
synaptic profiles from each section were used for quantification. A total
of 20 profiles were quantified in each group.
2.11. EM quantification and statistical analysis
The sections were examined with a Philips Fei Tecnai 12 electron
microscope at 60 kV. Electron micrographs were obtained at random
from the middle layer of stratum radiatum of the CA1 region of the
hippocampus. Specific plasma membrane and cytoplasmic compart-
ments were defined and used for quantifications. SNAP-25 im-
munolabeling was quantified as number of gold particles/μm over the
active zone. VAMP2 immunolabeling was quantified as number of gold
particles/μm2 over the presynaptic cytoplasm. The length of the active
zone was defined as equal to the length of the postsynaptic density of
the same synapse. Only synaptic profiles with clearly visible synaptic
membranes and postsynaptic density were selected for quantitative
analysis. The images were quantified with a commercially available
image analysis program (analySIS; Soft Imaging Systems, Münster,
Germany). Curves were drawn interactively and gold particles were
detected semiautomatically. An in-house extension to the analysis
software (Soft Imaging Systems) calculated area particle density
(number per unit area) over presynaptic cytoplasm for VAMP2 im-
munogold labeling and linear particle density (number per unit length
of curve) over active zone for SNAP-25 immunogold labeling. In the
latter case, it measured the distance from each particle-center to the
membrane and included only those particles, which were within an
operator-defined distance from the curve segment. For general plasma
membranes the inclusion distance was symmetric between +/−21 nm.
The inclusion distance was defined as the distance between the epitope
and the center of the gold particle, corresponding to the radius of the
particle (5 nm) and the length of the interposed primary antibody
(8 nm) and length of the secondary antibody (8 nm). Data for particles
were collected in ASCII files as flat tables and exported to SPSS (SPSS
Inc, Chicago, IL, USA) for further statistical and graphical analysis.
3. Results
3.1. Specificity of GA-protein antibodies
We evaluated the specificity of GA-protein antibodies at the electron
microscopical level by immunogold labeling of the hippocampus from
embryonic KO mice (Fig. 1). Quantification of SNAP-25 gold particles
over the active zone of presynaptic terminals (Fig. 1A) revealed only
18% labeling density in the KO mice (Fig. 1B4) compared to the WT
mice (Fig. 1B3) (n=20 in both groups, WT: 10.1 ± 1.9, KO:
1.8 ± 0.75, p < 0.001, Mann-Whitney U test). Quantitative analysis
of VAMP2 labeling over the presynaptic cytoplasm (Fig. 1C) showed
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only 13% labeling intensity in the KO animals (Fig. 1D4) compared to
the WT mice (Fig. 1D3) (n=20 in both groups, WT: 52.5 ± 9.1, KO:
6.7 ± 2.0, p < 0.001, Mann-Whitney U test). We further performed
immunogold labeling of sections from adult rat hippocampus with GA-
protein antibodies after pre-incubation with the same antigen used for
immunization of the rabbits (Fig. 1B2, D2). The analysis showed only
4% labeling density in the pre-incubation group for SNAP-25 (Fig. 1A)
compared to control (n=20 in both groups, ctrl: 18.2 ± 2.5, pre-inc:
0.8 ± 0.5, p < 0.001, Mann-Whitney U test) and 6% for VAMP2
(Fig. 1C) (n=20 in both groups, ctrl: 79.4 ± 6.2, pre-inc: 4.7 ± 1.7,
p < 0.001, Mann-Whitney U test).
3.2. Antibody sensitivity for fixed and non-fixed protein
In order to determine sensitivity of GA-protein antibodies compared
to that of commercially available standard antibodies for fixed protein,
we applied them to brain homogenate and synaptosomes on PVDF
membranes after fixation with a combination of GA and FA (Fig. 2).
Staining of brain homogenate and synaptosome fraction with anti-GA-
SNAP-25 and anti-GA-VAMP2 detected bands at respectively 25 and
18 kDa, the predicted molecular weight of these proteins. Anti-GA-
SNAP-25 antibody showed stronger bands on the fixed membrane
compared to the non-fixed membrane (Fig. 2A). Conversely, standard
poly- and monoclonal SNAP-25 antibodies showed stronger affinity for
proteins on the normal, unfixed membrane (Fig. 2B, C). Similar results
were observed with the anti-GA-VAMP2 antibody; immunostaining
revealed stronger band intensities on the fixed membrane (Fig. 2D),
while standard VAMP2 antibodies binds stronger to the non-fixed
membrane (Fig. 2E, F).
3.3. Immunofluorescence labeling of neuronal cultures
To further verify the quality of our antibodies, we performed
immunofluorescence labeling of dissociated hippocampal neuronal
cultures. GA-protein antibodies and standard antibodies were applied to
GA-fixed and FA-fixed neurons (Fig. 3). Staining with anti-GA-SNAP-25
showed distinct synaptic and dendritic profiles with limited background
(Fig. 3A and D). Immunolabeling with standard polyclonal and mono-
clonal SNAP-25 antibodies displayed blurred synapses and weak den-
dritic profiles (Fig. 3B, C, E, F). Staining of neuronal cultures with anti-
GA-VAMP2 showed clear, round and sharp synaptic profiles. No back-
ground labeling was observed (Fig. 3G, J). Staining with standard
VAMP2 polyclonal antibody (Fig. 3H, I, K, L) showed more background
and round blurry boutons with different sizes compared to labeling
with in house antibody.
3.4. Quantitative postembedding electron microscopy
To evaluate performance of the antibodies at the ultrastructural
level, we performed postembedding immunogold labeling of ultrathin
sections from the CA1 region of the hippocampus (Fig. 4). SNAP-25 is a
t-SNARE localized to the plasma membrane and found in high con-
centrations at sites for exocytosis of vesicles, like the presynaptic active
zone. Labeling with anti-GA-SNAP-25 was membrane associated as
expected. Many gold particles were located at the active zone (Fig. 4A).
Labeling with standard poly- and monoclonal SNAP-25 antibodies
showed low gold particle densities at the active zone (Fig. 4B, C).
VAMP2 is a v-SNARE localized on synaptic vesicles. Labeling with anti-
GA-VAMP2 was consistent with the expected ultrastructural localiza-
tion of the protein. Strong labeling intensity of vesicles in the pre-
synaptic cytoplasm was observed (Fig. 4D). Standard VAMP2 poly-
clonal and monoclonal antibodies also displayed the expected pattern,
however, the labeling intensity was low compared to GA-VAMP2 an-
tibody (Fig. 4E, F).
We then performed quantitative analyses of the immunogold la-
beling described above. SNAP-25 immunolabeling was quantified over
Fig. 1. Specificity of anti-GA-SNAP-25 and anti-GA-VAMP2
antibodies.
(A) Quantitative analysis of immunogold labeling with anti-
GA-SNAP-25 antibody at the active zone of hippocampal sy-
napses, preincubated with SNAP-25 protein and synapses from
SNAP-25 KO mice. (B) Electron micrographs displaying cor-
responding SNAP-25 immunogold labeling. Gold particles are
highlighted with squares. (B1) Standard labeling. (B2)
Labeling with antibody pre-incubated with SNAP-25 antigen.
(B3) Standard labeling of WT mice. (B4) Labeling of SNAP-25
KO tissue. (C) Quantitative analysis of immunogold labeling
with anti-GA-VAMP2 antibody of presynaptic cytoplasm at
hippocampal synapses, preincubated with VAMP2 protein and
synapses from VAMP2 KO mice. (D) Electron micrographs
displaying VAMP2 immunogold labeling. Gold particles are
highlighted with squares. (D1) Standard labeling. (D2)
Labeling with antibody pre-incubated with VAMP2 antigen.
(D3) Standard labeling of WT mice. (D4) Labeling of VAMP2
KO tissue. Embryonic (E18) WT and KO mice were used for
immunogold labeling. Pre-incubation experiments were per-
formed in adult rats. Scale bars (B) 50 nm. (D) 100 nm.
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the active zone as gold particles/μm membrane length. Mean gold
particle density with anti-GA-SNAP-25 was 35.7 ± 2.1 (Fig. 4G). The
corresponding value for standard polyclonal and monoclonal antibodies
against SNAP-25 was 4.1 ± 0.8 and 4.0 ± 0.8 (Fig. 4G). Statistical
calculation revealed significant differences between GA-SNAP-25 anti-
body and both of the standard antibodies (n=60 in each group, p <
0.001, Mann-Whitney U test). Analysis did not show significant differ-
ences between the standard poly and monoclonal antibodies, (n= 60 in
both groups, p= 0,998, Mann-Whitney U test). Mean gold particles/
μm2 over presynaptic cytoplasm with the anti-GA-VAMP2 was
248.3 ± 9.1 (Fig. 4H). The mean numbers of gold particles/μm2 with
the standard polyclonal and monoclonal antibodies against VAMP2
were respectively 29.2 ± 2.2 and 39.6 ± 3.0 (Fig. 4H). Statistical
analysis revealed significant differences in labeling intensity between
GA-VAMP2 antibody and the both the standard antibodies (n=60 in
each group, p < 0.001, Mann-Whitney U test). No significant change
was detected in labeling density between the standard poly and
monoclonal VAMP2 antibodies (n=60 in both groups, p= 0.433,
Mann-Whitney U test).
3.5. Sensitivity of GA-protein antibodies for glutaraldehyde fixed tissue
Our antibodies were raised against GA-fixed antigen. To clarify
whether these GA-protein antibodies have higher affinities for protein
fixed with GA compared to FA fixed proteins, the GA-protein antibodies
were applied to ultrathin brain sections fixed with GA and ultrathin
brain sections fixed with FA (Fig. 5). Immunogold labeling with anti-
GA-SNAP-25 and anti-GA-VAMP2 showed significantly higher labeling
density, respectively, of the active zone (Fig. 5A) and the presynaptic
cytoplasm (Fig. 5D) in GA compared to FA fixed brains (Fig. 5B, E).
Quantification of SNAP-25 immunogold labeling over the active zone
revealed 18.9 ± 1.2 gold particles in GA and 5.1 ± 0,8 in FA fixed
synapses (Fig. 5C) (n= 50 in both groups, p < 0.001, Mann-Whitney
U test). Mean number of gold particles/μm2 over the presynaptic cy-
toplasm with anti-GA-VAMP2 was 184.9 ± 6.7 in GA and 43.9 ± 3.3
in FA fixed tissue (Fig. 5F) (n=50 in both groups, p < 0.001, Mann-
Whitney U test).
Affinity of our GA-protein antibodies for GA-fixed epitopes was
additionally evaluated by DAB peroxidase labeling of LM sections fixed
with GA and LM sections fixed with FA (Fig. 6). Staining intensity was
clearly stronger in the GA-fixed brain slices with both GA-SNAP-25 and
GA-VAMP2 antibody (Fig. 6A, C). Labeling was characteristically
punctate in the synaptic areas of hippocampal CA1 region in the GA
group, while labeling was almost absent or very weak in the same area
of FA-fixed brain (Fig. 6B, D). Syntaxin1 is a t-SNARE with a similar
localization pattern as SNAP-25 in synapses. DAB peroxidase labeling
with commercially available standard anti-syntaxin1 raised against
non-fixed antigen was used as control. Staining of LM sections with
anti-syntaxin1 displayed equally strong labeling intensity of GA- and
FA-fixed brain sections (Fig. 6E, F).
4. Discussion
In addition to conventional problems like antibody specificity,
tissue treatment procedures necessary for EM visualization almost
without exception mask or denature the protein antigens in a way to
hinder antibody binding (Mathiisen et al., 2006). One way of over-
coming many of these problems, is to perform pre-embedding labeling,
prior to many of the denaturing procedures. However, pre-embedding
techniques are not optimal for quantitative analysis due to local dif-
ferences in penetrability of the tissue. Among the denaturing or
masking procedures are: fixation with GA, contrast staining with os-
mium, uranyl acetate and lead citrate, dehydration, and embedding in
resin. In addition, many resins require elevated temperatures to cure.
Thus, in order to minimize denaturing of proteins during the embed-
ding procedure, we used a well established, freeze substitution proce-
dure (Mathiisen et al., 2006) where tissue is dehydrated and embedded
under very low temperatures, also allowing a not complete dehydra-
tion, thus minimizing the usual denaturing effects. In addition, this
material is not post-fixed in osmium, and the concentration of GA is
kept to a minimum (0.1–0.25%, compared to, e.g., 2.5–4.0 % in con-
ventional EM techniques). However, the ultrastructure of the tissue is
poor compared to conventional EM. Still, even with these procedures,
postembedding immunogold labeling is a challenge. The relatively
weak fixation with GA still denatures the proteins sufficiently to reduce
antibody binding efficiency. For structural protein antigens present in
high concentrations in the tissue, this may not always pose a practical
problem. However, for regulatory proteins, e.g. SNARE proteins or
neurotransmitter receptors, this may still present a significant chal-
lenge. With such proteins, present in the membrane or cytoplasm in
comparatively low concentrations, only few commercially available
antibodies against peptides provide a quantifiable signal with these EM
procedures.
The specificity of our antibodies were evaluated at ultrastructural
level by immunogold labeling of brain sections from the KO mice and
immunogold labeling after pre-incubation with the same antigen used
for immunization of the rabbits. The results clearly demonstrated that
denaturation of antigen prior to immunization does not reduce the
specificity of the antibodies (Fig. 1).
Others have tried a similar approach previously (Harrach and
Robenek, 1990). They raised polyclonal antibodies against
Fig. 2. Comparison of anti-GA-SNAP-25 and anti-GA-VAMP2 antibodies with
corresponding standard antibodies on fixed and unfixed WB membranes.
Western blots of rat brain homogenate (BH) and synaptosomes (S) labeled with
anti-GA-SNAP-25 and anti-GA-VAMP2 antibodies and corresponding standard
antibodies against SNAP-25 and VAMP2. Antibodies were applied on blotted
membranes fixed with a combination of 4.0% FA+0.1% GA or on normal non-
fixed membranes. (A) Anti-GA-SNAP-25. (B) Standard polyclonal anti-SNAP-25.
(C) Standard monoclonal anti-SNAP-25. (D) Anti-GA-VAMP2. (E) Standard
polyclonal anti-VAMP2. (F) Standard monoclonal anti-VAMP2.
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apolipoprotein pre-fixed with FA. The antibodies reacted specifically
and recognized fixed as well as unfixed apolipoprotein in ELISA and WB
analysis. The efficacy of the antibodies was further tested at the elec-
tron microscopical level showing specific labeling localized to the cis-
ternae of the
rough endoplasmic reticulum, the Golgi complex, and in vesicles
associated with the Golgi region. Furthermore, Harrach and colleagues
were able to localize apolipoprotein in foam cells of the human aortic
plaque by postembedding immunocytochemistry. In control experi-
ments carried out by using antibodies pre-adsorbed with the antigen, no
labeling was observed. Riederer also generated antibodies against an-
tigen pre-fixed with FA for use in immunohistochemical procedures
(Riederer, 1993). The large subunit of neurofilaments was exposed to
FA and used for immunization of rabbit. In aldehyde fixed cerebellum,
the antibody strongly stained axons. In contrast, in alcohol-fixed cryo-
stat sections the immunocytochemical detection was substantially re-
duced. Danbolt and colleagues (Danbolt et al., 1992) successfully raised
antibodies against antigen treated with a mixture of FA and GA for use
in immunohistocytochemical applications. We (Bock et al., 1997) and
others (Fujiwara and Masuyama, 1995; Mera et al., 2008) have also
used GA as cross-linker to conjugate proteins and produce epitope-
specific antibodies. Although there are several studies reporting the
potential of antibodies made against fixed proteins, no other studies
have so far systematically evaluated the quality of antibodies raised
against antigen pre-fixed with GA for use in EM.
In the present study we show that antibodies raised against fixed
antigen in fact more readily binds to fixed, denatured, protein com-
pared to native, unfixed protein, while reduced antigenicity of fixed
proteins were observed for the commercial antibodies. The concentra-
tion of GA-protein antibodies was kept low to highlight the differences,
at higher concentration these antibodies displayed strong im-
munoreactivity also of untreated antigen. Thus, our antibodies were
shown to interact satisfactorily with both aldehyde treated antigen and
normal antigen in a biochemical application.
Fig. 3. Immunofluorescence staining of aldehyde-fixed
dissociated hippocampal cultures with anti-GA-SNAP-25
and anti-GA-VAMP2, compared to staining with corre-
sponding standard antibodies.
Confocal images of dissociated hippocampal neuronal
cultures immunostained with anti-GA-SNAP-25, anti-GA-
VAMP2, or corresponding standard antibodies against the
same proteins. The antibodies were applied to neuronal
cultures fixed with 2.5% GA and neuronal cultures fixed
with 4.0% FA. (A) GA fixed neuronal culture stained with
anti-GA-SNAP-25. (B) GA fixed neuronal culture stained
with standard polyclonal anti-SNAP-25. (C) GA fixed
neuronal culture stained with standard monoclonal anti-
SNAP-25. (D) FA fixed neuronal culture stained with anti-
GA-SNAP-25. (E) FA fixed neuronal culture stained with
standard polyclonal anti-SNAP-25. (F) FA fixed neuronal
culture stained with standard monoclonal anti-SNAP-25.
(G) GA fixed neuronal culture stained with anti-GA-
VAMP2. (H) GA fixed neuronal culture stained with stan-
dard polyclonal anti-VAMP2. (I) GA fixed neuronal culture
stained with standard monoclonal anti-VAMP2. (J) FA
fixed neuronal culture stained with anti-GA-VAMP2. (K)
FA fixed neuronal culture stained with standard polyclonal
anti-VAMP2. (I) FA fixed neuronal culture stained with
standard monoclonal anti-VAMP2. Scale bars: 5 μm.
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However, conditions are different in immunocytochemical staining
of intact cells. Fixation of tissue with GA decreases antibody penetra-
tion of antibodies (Pow, 1997). Moreover, GA fixation creates auto-
fluorescent compounds (Rost and Ewen, 1971) and has shown to in-
crease background immunofluorescence due to non-specific binding of
antibodies to unintended proteins (Mundegar et al., 2008). In our study,
we did not observe autofluorescence or decreased tissue penetration of
the antibodies, indicating advantage of GA-proteins antibodies for im-
munofluorescence assays. Furthermore, significantly stronger labeling
intensity of GA fixed brains compared to FA treated sections with our
antibodies confirmed that immunoreactivity significantly increases by
selecting the same fixative for fixation of the tissue as for modifying
antigen before immunization.
The main purpose of making antibodies against GA treated antigens
was to improve immunolabeling at the ultrasctructural level. We took
advantage of GA-SNAP-25 and GA-VAMP2 antibodies in our recent
publications (Hussain and Davanger, 2015; Hussain et al., 2018). In
these studies we showed novel electron microscopical data of SNAP-25
and VAMP2 expression in postsynaptic spines from the CA1 region of
the hippocampus. We believe that these antibodies have uncovered
localization of SNARE proteins in the brain that has not been
demonstrated previously. In the present work, our antibodies produced
strong labeling of synaptic terminals. Though also standard antibodies
showed labeling of VAMP2 and SNAP-25 positive structures, the la-
beling intensity was not satisfying despite high concentrations of the
antibodies. Thus, GA-protein antibodies were shown to be superior to
corresponding standard commercial antibodies. Our results highlight
the experimental potential of raising antibodies against GA-treated
antigen to improve sensitivity of the antibodies for postembedding
immunogold EM.
Declaration of interest
The University of Oslo supported this work. The authors declare that
they have no competing interests.
Ethical standards agreement
I have read and have abided by the statement of ethical standards
for manuscripts submitted to the Journal of Neuroscience Methods.
Fig. 4. Quantitative EM of synapses in the
hippocampus labeled with anti-GA-SNAP-25,
anti-GA-VAMP2, or corresponding standard
antibodies.
Electron micrographs showing SNAP-25 and
VAMP2 immunogold labeling of asymmetric
synapses from the CA1 region of the hippo-
campus fixed with a combination of 4.0%
FA+0.1% GA. (A) Anti-GA-SNAP-25 labeling.
(B) Standard polyclonal anti-SNAP-25 labeling.
(C) Standard monoclonal anti-SNAP-25 la-
beling. (D) Anti-GA-VAMP2 labeling. (E)
Standard polyclonal anti-VAMP2 labeling. (F)
Standard monoclonal anti-VAMP2 labeling.
(G) Quantitative analysis of SNAP-25 im-
munogold labeling. (H) Quantitative analysis
of VAMP2 immunogold labeling. Scale bars:
100 nm.
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